Veru Inc. SEC filings VERU
Veru Inc. has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2007. Its latest annual report, Form 10-K, was filed on Dec 17, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 15, 2026 | — |
| EFFECT | Filing | Apr 15, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2026 | — |
| EFFECT | Filing | Dec 16, 2024 | — |
| DEFR14A | Filing | May 9, 2024 | — |
| NT 10-Q | Filing | Feb 15, 2024 | Dec 31, 2023 |
| EFFECT | Filing | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 22, 2023 | — |
| UPLOAD | Letter from the SEC | May 19, 2023 | — |
| EFFECT | Filing | Apr 14, 2023 | — |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2023 | — |
| EFFECT | Filing | Aug 14, 2020 | — |
| EFFECT | Filing | Jul 1, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2020 | — |
| CORRESP | Letter to the SEC | Jun 30, 2020 | — |
| NT 10-K | Filing | Jan 2, 2018 | Sep 30, 2017 |
| EFFECT | Filing | Nov 14, 2017 | — |
| D | Filing | Nov 9, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2016 | — |
| CORRESP | Letter to the SEC | Jul 18, 2016 | — |
| PRER14A | Filing | Jul 18, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2016 | — |
| CORRESP | Letter to the SEC | Jun 21, 2016 | — |
| PRER14A | Filing | Jun 21, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2016 | — |
| NO ACT | Auto-generated paper document | Dec 4, 2015 | Nov 3, 2015 |
| UPLOAD | Letter from the SEC | Sep 3, 2015 | — |
| CORRESP | Letter to the SEC | Sep 1, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2015 | — |
| NO ACT | Auto-generated paper document | Jan 8, 2015 | Dec 11, 2014 |
| UPLOAD | Letter from the SEC | Apr 6, 2010 | — |
| CORRESP | Letter to the SEC | Apr 1, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2010 | — |
| CORRESP | Letter to the SEC | Mar 11, 2010 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2010 | — |
| CERTNAS | Auto-generated paper document | Jun 8, 2009 | — |
| 25 | Female health company form 25 | Jun 8, 2009 | — |
| 8-A12B | Female health company form 8-a | Jun 8, 2009 | — |
| 10QSB | Fhc june 30, 2008 form 10-qsb | Aug 12, 2008 | Jun 30, 2008 |
| UPLOAD | Letter from the SEC | Jun 13, 2008 | — |
| 10QSB | Fhc march 31, 2008 form 10-qsb | May 14, 2008 | Mar 31, 2008 |
| UPLOAD | Letter from the SEC | Mar 13, 2008 | — |
| CORRESP | Letter to the SEC | Feb 28, 2008 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2008 | — |
| 10QSB | Fhc december 31, 2007 form 10-qsb | Feb 13, 2008 | Dec 31, 2007 |
| CORRESP | Letter to the SEC | Feb 11, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2008 | — |
| 10KSB | Fhc september 30, 2007 form 10-ksb | Dec 21, 2007 | Sep 30, 2007 |
| 10QSB | Fhc june 30, 2007 form 10-qsb | Aug 14, 2007 | Jun 30, 2007 |
| CERTAMX | Auto-generated paper document | Jul 6, 2007 | — |
| 8-A12B | Fhc form 8-a | Jul 6, 2007 | — |
| 10QSB | Female health company march 31, 2007 form 10-qsb | May 14, 2007 | Mar 31, 2007 |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERU (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- WI
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 863894
- Former names
- FEMALE HEALTH CO (until Aug 1, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.